AMPH vs BDX · P/E 12, rev $732.0M vs P/E 34, rev $21.84B
Amphastar P (AMPH) versus Becton Dickinson and Company (BDX) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Not investment advice. Open the AMPH and BDX stock pages for the full models.
Not investment advice.